NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fuze Health

Fuze Health

Private
New York City, New YorkHealthcare & Life Scienceshttps://fuzehealth.com/

Last Round

Series D

Extension

Sep 8, 2022

Est. Valuation

$1.6B

Total Funding Raised

$541.8M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Fuze Health is a healthcare technology company that provides an integrated platform for personalized home healthcare, including diagnostics, virtual care, and pharmacy services.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Pharma Supply Chain, Patient Engagement, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

digital pharmacye-pharmacydiagnostic testingmedication adherenceAPI platformgenomic screeninghub servicespatient accesscare coordinationhealthcare infrastructureprescription fulfillmenthealth techelectronic health record integrationEHR integrationrisk stratification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fuze Health Comparables

Compare Fuze Health with similar companies based on industry and business-model similarity.

Fuze Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Everly Health
74%
HealthDyne
73%
EVERSANA
70%

Fuze Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionSep 8, 2022
Series DOct 27, 2021
Series DJun 8, 2021
Series CSep 9, 2020
Series BJul 8, 2020
Series C
May 6, 2020

Key People

Founding team and executive leadership

Oonagh O'Brien

CEO, Fuze Services, Product Strategy, Fuze Technologies

Executive Team

Paul Greenall

CEO, FuzeRx And Chief Development Officer, Fuze Health

Executive Team

Amer Waheed

Chief Technology Officer, FuzeRx

Executive Team

Mike Tesar

Chief Technology Officer

Executive Team

Fuze Health Investors

Notable investors and investment history

Fuze Health investors
InvestorRounds
Slow VenturesSeed
Deerfield ManagementSeries C
Transpose Platform ManagementSeries C, Series D, Series B
Oak HC/FTSeries C
Tuesday CapitalSeries A
Optum VenturesSeries C, Series B, Series D, Series A
Morgan HealthSeries D Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 6, 2026

    Open roles increased from 0 to 267, representing 172% of current headcount.

  • Jun 1, 2026

    Grew 42% QoQ, from 109 to 155 employees.

Fuze Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fuze Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fuze Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range159
Year Founded2025
Last FundingSep 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.